Colorectal: cancer-metastasis-normal

Rate this item
(0 votes)
Category Human tissue array
   Cat. No. CDA
   Product description colorectal: cancer-metastasis-normal
   Data sheet CDA2
CDA2
     
  general_information
   No. of samples 59
   Text
current version : CDA2 
cancer :40 cores 
metastatic cancer :10 cores 
normal :9 cores

Price : 5slide for 600 $

CDA2  Human, colon and rectal cancer
               
  Age  Sex Site Pathology TNM Stage Months*
1 40 F sigmoid adenocarcinoma, W/D T3N2M0 ⅢC .
2 65 F cecum Mucinous adenocarcinoma T3N2M0 ⅢC .
3 56 M ascending adenocarcinoma, M/D T4N1M0 ⅢB .
4 65 F sigmoid adenocarcinoma, W/D T3N0M0 ⅡA .
5 62 M ascending adenocarcinoma, M/D T3N0M0 ⅡA .
6 57 F sigmoid adenocarcinoma, W/D T3N1M0 ⅢB .
7 78 M sigmoid adenocarcinoma, W/D T3N1M0 ⅢB .
8 45 M rectum adenocarcinoma, W/D T3N1M0 ⅢB .
9 65 M ascending adenocarcinoma, W/D T3N1M0 ⅢB .
10 61 M transverse Mucinous adenocarcinoma T3N0M0 ⅡA .
11 52 M rectum adenocarcinoma, M/D T3N0M1 .
12 52 F sigmoid adenocarcinoma, M/D T2N2M0 ⅢC .
13 47 F cecum adenocarcinoma, M/D T3N0M0 ⅡA .
14 63 F descending adenocarcinoma, M/D T3N1M0 ⅢB .
15 53 M cecum adenocarcinoma, M/D T3N1M0 ⅢB .
16 53 F transverse adenocarcinoma, W/D T3N0M0 ⅡA .
17 64 M sigmoid adenocarcinoma, M/D T3N1M0 ⅢB .
18 59 M sigmoid adenocarcinoma, M/D T4N0M0 ⅡB .
19 57 M ascending adenocarcinoma, M/D T4N0M0 ⅡB .
20 59 M ascending adenocarcinoma, M/D T3N0M0 ⅡA .
21 35 F ascending Mucinous adenocarcinoma T3N0M0 ⅡA .
22 49 F ascending adenocarcinoma, M/D T3N2M0 ⅢB .
23 76 M sigmoid adenocarcinoma, M/D T3N1M1 .
24 74 M ascending adenocarcinoma, M/D T3N0M0 ⅡA .
25 60 F rectum adenocarcinoma, M/D T4N0M0 ⅡB .
26 62 M sigmoid adenocarcinoma, M/D T3N0M0 ⅡA .
27 57 M sigmoid adenocarcinoma, M/D T3N0M0 ⅡA .
28 56 F sigmoid adenocarcinoma, M/D T3N2M1 .
29 75 F rectum adenocarcinoma, W/D T3N1M0 ⅢB .
30 58 M rectum adenocarcinoma, M/D T3N0MX ⅡA .
31 62 M rectum adenocarcinoma, M/D T4N1M0 ⅢB .
32 65 F cecum Mucinous adenocarcinoma T3N2M0 ⅢC .
33 36 M transverse adenocarcinoma, M/D T3N2M0 ⅢC .
34 . F descending adenocarcinoma, W/D T4N1M1 .
35 46 F ascending adenocarcinoma, P/D T3N2MX ⅢC .
36 42 M transverse adenocarcinoma, M/D T3N2M0 ⅢC .
37 62 M sigmoid adenocarcinoma, M/D T3N2M1 .
38 41 F sigmoid adenocarcinoma, W/D T4N2M1 .
39 51 M rectum adenocarcinoma, M/D T4N2M0 ⅢC .
40 47 F sigmoid adenocarcinoma, M/D T4N1M1 .
41 66 M lung metastatic adenocarcinoma from #31 . . 42
42 65 F lymph node metastatic carcinoma from #32 . . 0
43 36 M lymph node metastatic carcinoma from #33 . . 0
44 . F ovary metastatic adenocarcinoma from #34 . . 0
45 46 F lymph node metastatic carcinoma from #35 . . 0
46 42 M lymph node metastatic carcinoma from #36 . . 0
47 62 M lymph node metastatic carcinoma from #37 . . 0
48 41 F ovary metastatic adenocarcinoma from #38 . . 0
49 52 M lung metastatic adenocarcinoma from #39 . . 17
50 47 F ovary metastatic adenocarcinoma from #40 . . 0
51 40 F sigmoid normal colon (adjacent to cancer, match of #1) . . .
52 68 M sigmoid normal colon (adjacent to cancer, match of #2) . . .
53 45 M rectum normal colon (adjacent to cancer, match of #8) . . .
54 62 M sigmoid normal colon (adjacent to cancer, match of #26) . . .
55 42 M transverse normal colon (adjacent to cancer, match of #36) . . .
56 49 F ascending normal colon (apart from cancer, match of #22) . . .
57 76 M sigmoid normal colon (apart from cancer, match of #23) . . .
58 36 M transverse normal colon (apart from cancer, match of #33) . . .
59 62 M sigmoid normal colon (apart from cancer, match of #37) . . .
60 carbon            
               
*: interval between primary and metastatic cancer        
   W/D, well differentiated; M/D, moderately differentiated; P/D, poorly differentiated      
TNM Classification : Colon and Rectum carcinoma (AJCC 6th Edition)      

General Information of the Tissue Array Slide :

Applications

  • Immunohistochemistry
  • In situ hybridization, RNA or DNA
  • Fluorescent in situ hybridization (FISH)
  • In situ PCR, RNA or DNA
  • TUNEL for apoptosis (Recommended procedures in www.tissue-array.com -> protocol)

Storage and stability

  • Individual slide is paraffin-coated and put in an air-tight pack with inert gas.
  • Tissue array slides are shipped in room temperature.
  • If the slides are stored in 4 degree, they are good up to one year.

How processed

  • Tissues were initially fixed with formalin except for some of the animal tissues.
  • Then, dehydrated with gradient ethanol; typically 1 hour each progressive steps; 70%, 90%, 95%, 99%, 100% x 3 times.
  • Cleared by xylene, three changes for 1 hour each.
  • Infiltrated with 60°C paraffin, three changes for 1 hour each
  • Microtoming in 4 µm thickness and put on silane coating slide from Muto Pure Chemicals (Japan)

Before use

  • Dry slides for 1 hour in a oven at 60 degree.
  • Dewax slides in xylene for 4 minutes x 5 times
  • Hydrate slides in 100%, 95% and 75% ethanol for 3 minutes x 2 times each.
  • Immerse slides in tap water for 5 minutes

Slide orientation

  • In most of the slides with 59 or 60 cores, the orientation is as below unless indicated otherwise. #60 location is usually filled with carbon for orientation.

Shaded area

1 2 3 4 5 6 7 8 9 10
11 12 13 14 15 16 17 18 19 20
21 22 23 24 25 26 27 28 29 30
31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50
51 52 53 54 55 56 57 58 59 60
Read 1631 times

Tags